方新侠YY
04-29
$艾迪康控股(09860)$
2024年肿瘤检测业务同比大增47%,特检收入五年复合增长率33%。AI技术深度融入精准医疗,驱动高毛利特检服务渗透率提升,长期增长逻辑明确。
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":429535408136568,"tweetId":"429535408136568","gmtCreate":1745888864755,"gmtModify":1745888866370,"author":{"id":4111461471939460,"idStr":"4111461471939460","authorId":4111461471939460,"authorIdStr":"4111461471939460","name":"方新侠YY","avatar":"https://static.tigerbbs.com/9c047f61fcd0850109e2b3261bd2ddc4","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/09860\">$艾迪康控股(09860)$ </a> 2024年肿瘤检测业务同比大增47%,特检收入五年复合增长率33%。AI技术深度融入精准医疗,驱动高毛利特检服务渗透率提升,长期增长逻辑明确。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/09860\">$艾迪康控股(09860)$ </a> 2024年肿瘤检测业务同比大增47%,特检收入五年复合增长率33%。AI技术深度融入精准医疗,驱动高毛利特检服务渗透率提升,长期增长逻辑明确。</p></body></html>","text":"$艾迪康控股(09860)$ 2024年肿瘤检测业务同比大增47%,特检收入五年复合增长率33%。AI技术深度融入精准医疗,驱动高毛利特检服务渗透率提升,长期增长逻辑明确。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/429535408136568","repostId":0,"isVote":1,"tweetType":1,"viewCount":851,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09860"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":144,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/429535408136568"}
精彩评论